Martin Demarchi
2PUBLICATIONS
0CO-AUTHORS
Get your video featured.
Publish with JoVEGet your video featured.
Publish with JoVE
Publications (2)
Sort by Publication Date:
|Sep 23, 2021
A randomized phase I study comparing the pharmacokinetics of a bevacizumab (HD204) biosimilar to European Union- and United States of America-sourced bevacizumab.Martin Demarchi, Pierre Coliat, Philippe Barthelemy
|Jul 26, 2021
TROIKA-1: A double-blind, randomized, parallel group, study aimed to demonstrate the equivalent pharmacokinetic profile of HD201, a potential biosimilar candidate to trastuzumab, versus EU-Herceptin<sup>®</sup> and US-Herceptin<sup>®</sup> in healthy male subjects.Martin Demarchi, Pierre Coliat, Kristi Mclendon
Pageof 1
